Kalypsys announced last week the appointment of David Tiemeier as the company’s chief commercial officer.
Tiemeier joins Kalypsys from Immtech International, where he was vice president of licensing and development. Prior to that, Tiemeier was the vice president of business development at NeoPharm. He has also been employed by Monsanto, Searle, and Pharmacia.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
